baber/WOPTO huggingface dataset:
Patent MX-PA02001016-A (MX)
Title: Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines.
Inventor: LYDIE POITOUT
IPC: A61P35/00
Filed: 2000-07-28
Abstract: The invention concerns compounds for treating pathological conditions or diseases wherein one (or several) somatostatin receptors is (are) involved, corresponding to general formula (I) wherein: R1 represents in particular a carbocyclic or heterocyclic aryl radical optionally substituted or a nonaromatic heterocyclic radical optionally substituted; R2 represents H, alkyl or aryl optionally substituted; R3 represents H or (CH2)pZ3, Z3 representing in particular alkyl, cycloalkyl, bisarylalkyl or diaryalkyl, Y1(CH2)pphenyl(X1)n, carbocyclic or heterocyclic aryl optionally substituted, a nonaromatic heterocyclic radical optionally substituted, X1, every time it is present, being independently selected in particular among the radicals H, Cl, F, Br, I, CF3, NO2, OH, NH2, CN, N3, OCF3, alkyl, alkoxy, Salkyl, (CH2)pNH2, (CH2)pNHalkyl, (CH2)pNdialkyl; Y1 represents O, S, NH or is not present; R4 represents (CH2)pZ4, Z4 representing in particular amino, alkylamino, N,Ndialkylamino; R5 represents in particular H or alkyl; X represents O or S; p each time it is present is independently 0 or an integer ranging between 1 and 6; q each time it is present is independently an integer between 1 and 5; n represents 0 or 1; provided that when n represents 0, m represents 1, 2 or 3, and when n represents 1, m represents 0 or 1.
Patent MX-PA02002398-A (MX)
Title: Flexible stent.
Inventor: ROBERT BURGERMEISTER
IPC: A61F2/90
Filed: 2002-03-04
Abstract: A preferred embodiment of a stent provides a folded strut section that provides both structural rigidity and reduction in foreshortening of the stent mechanism. A flexible section provides flexibility for delivery of the stent mechanism. In a second embodiment, flexible section columns are angled with respect to each other, and to the longitudinal axis of the stent. These relatively flexible sections are oppositely phased in order to negate any torsion along their length. In yet another embodiment, the flexible connector can take on an undulating shape (like an "N"), but such that the longitudinal axis of the connector is not parallel with the longitudinal axis of the stent. Finally, a new method is disclosed for making stents. The method consists of performing a standard photochemical machining process of cutting, cleaning and coating the tube with a photoresist. However, unlike former methods, the photoresist image is developed on the surface of the cylindrical metallic tube, which results in a controlled variable etching rate at selected sites on the cylindrical metallic tube during the etching process. Further embodiments provide living hinge connectors and connections along the length of the radial strut member.
Patent MX-PA02005356-A (MX)
Title: Method and system for tracking and rewarding connection timeto a network resource.
Inventor: THADDEUS MARSHALL
IPC: G06Q30/00
Filed: 2000-11-29
Abstract: A method for tracking and rewarding connection time from client systems to network resources includes the steps of enrolling individuals in a program, commencing an accumulation session when an individual connects to a participant s resource, such as an Internet website, tracking the length of time of an accumulation session and the quality of the attention demonstrated by the individual during the measured period of connection time, and calculating a credit value based on the length of time and quality of attention. (items 100, 105, 110). The greater the length of time and the quality of attention, the greater the credit value. A quality measure of individual attention specific to the individual may be calculated based on quality of attention as measured by responses to prompts. This quality measure may also be a factored that is credits that are accumulated and subsequently earned. The quality of the attention demonstrated by the user may be measured by offering various types of prompts throughout an accumulation session, and recording the length of time between an offered prompt and the provided response by the user, if any. A central program administrator may maintain records relating to the backgrounds of each user and participant resources may provide information recorded at accumulation sessions to the program administrator.
Patent MX-PA02005358-A (MX)
Title: Ceramic components for high pressure oil wells.
Inventor: IBRAHIM M MENTESH
IPC: E21B43/12
Filed: 2000-11-28
Abstract: A pressure reducing assembly for high pressure oil wells is disclosed. The assembly includes a metallic body having inlet and outlet channels that are lined with ceramic inserts. The assembly may also include a removable pressure reducing device that is preferably formed of a ceramic material. Pipe spool pieces associated with the pressure reducing assembly transition the narrow interior flow diameter of the assembly to the larger interior flow diameter of downstream oil process piping. The spool pieces have metallic bodies, with flow channels that are lined with ceramic inserts. The ceramic inserts are disposed within the metallic spool, and are preferably designed with a flow channel taper that gradually increase the interior flow diameter from that of the outlet channel of the pressure reducing assembly to that of the process piping. The use of the ceramic inserts and liners in the pressure reducing assembly provides a method for increasing the operating life of the flow control components of high pressure oil wells.
Patent MX-PA02005554-A (MX)
Title: Goods label.
Inventor: MANFRED FRIES
IPC: G06K19/077
Filed: 1999-12-07
Abstract: The invention relates to a goods label (1), which comprises a semi conductor chip (2) and an aerial (3), by means of which information stored in the semi conductor chip, about the goods, may be transmitted to a reading device. The aerial comprises a pre determined breaking point (4), in the region of which the aerial may be broken, by the energy from the reading device, during the reading process, such that a only limited number of reading cycles may be employed.
Patent MX-PA02006673-A (MX)
Title: NOVEL PROCESS FOR THE PREPARATION OF agr;(24DISULFOPHENYL)NTERTBUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF.
Inventor: WILCOX ALLAN
IPC: C07C309/46
Filed: 2001-01-04
Abstract: An integrated process for preparing agr;(2, 4disulfophenyl)Ntertbutylnitrone and its salts is disclosed in whichNtertbutylhydroxylamine acid addition salt is incompletely neutralised so as to leave catalytic amounts of acid and the neutralisation product is condensed with an appropriate aldehyde.
Patent MX-PA02008926-A (MX)
Title: Bed siderail.
Inventor: ZERHUSEN ROBERT MARK
IPC: A61G7/05
Filed: 2001-01-31
Abstract: A bed is provided having a bedframe, a first pair of siderails, and a second pair of siderails. The bedframe includes an articulating deck having first and second sections that move relative to each other. The first pair of the siderails is coupled to the second section of the deck to move therewith. At least one pair of the siderails is configured to move relative to the other pair of siderails to compensate for movement of the first pair of siderails with the second section of the deck.
Patent MX-PA02010531-A (MX)
Title: Method for inducing viral resistance in plants.
Inventor: KOEHLE HARALD
IPC: A01N37/50
Filed: 2001-04-30
Abstract: The invention relates to a method for inducing viral resistance in plants which is characterized in that the plants, the soil or seeds are treated with an effective quantity of a compound, which is absorbed by the plants or seeds and which is of formula (I), wherein: X represents halogen C1 C4 alkyl or trifluoromethyl; m is equal to 0 or 1; Q represents C(=CH CH3) COOCH3, C(=CH OCH3) COOCH3, C(=CH OCH3) CONHCH3, C(=N OCH3) COOCH3, C(=N OCH3) CONHCH3 or N( OCH3) COOCH3; A represents O B, CH2O B, OCH2 B, CH=CH B, C=C B, CH2O N=C(R1) B or CH2O N=C)R1) C(R2)=N OR3, whereby B represents optionally substituted phenyl, naphthyl, 5 member or 6 member hetaryl or 5 member or 6 member heterocyclyl, containing one to three N atoms and or one O or S atom or one or two O and or S atoms; R1 represents hydrogen, cyano, alkyl, alkyl halide, cycloalkyl, alkoxy; R2 represents optionally substituted phenyl, phenylcarbonyl, phenylsulfonyl, 5 member or 6 member hetaryl, 5 member or 6 member hetaryl carbonyl or 5 member or 6 member hetaryl sulfonyl, or alkyl, cycloalkyl, alkenyl, alkynyl, alkylcarbonyl, alkenylcarbonyl, alkynylcarbonyl, alkylsulfonyl or C(=NORagr;) ORbgr;, and; R3 represents hydrogen and optionally substituted alkyl, alkenyl and alkynyl.
Patent MX-PA02010825-A (MX)
Title: Multiple riser reactor.
Inventor: COUTE NICOLAS P
IPC: B01J8/18
Filed: 2001-04-27
Abstract: The present invention is directed to a hydrocarbon conversion apparatus. The apparatus comprises the following: a plurality of riser reactors, each of the riser reactors having a first end into which a catalyst can be fed and a second end through which the catalyst can exit the riser reactor, a separation zone into which the second ends of the riser reactors extend, the separation zone being provided to separate the catalyst from products of a reaction conducted in the hydrocarbon conversion apparatus; and at least one catalyst return in fluid communication with the separation zone and the first ends of the riser reactors, the catalyst return being provided to transfer the catalyst from the separation zone to the first ends of the riser reactors.
Patent MX-PA02012032-A (MX)
Title: Diagnostic methods for pompe disease and other glycogen storage diseases.
Inventor: MILLINGTON DAVID S
IPC: G01N33/483
Filed: 2001-06-06
Abstract: Provided are methods of screening subjects for lysosomal storage diseases, preferably glycogen storage diseases, using a tetrasaccharide as a biomarker. In a more preferred embodiment, subjects are screened for Pompe disease (i.e., glycogen storage disease type II). Also provided are neonatal screening assays. The present invention further provides methods of monitoring the clinical condition and efficacy of therapeutic treatment in affected subjects. Further provided are methods of measuring a tetrasaccharide biomarker by tandem mass spectrometry, preferably, as part of a neonatal screening assay for Pompe disease.
Patent MX-PA03000578-A (MX)
Title: Regenerator.
Inventor: SAMSON RENE
IPC: C10G11/18
Filed: 2001-07-17
Abstract: Regenerator vessel provided with means to supply catalyst particles, means to supply an oxygenate gas, means to discharge regenerated catalyst, means to discharge combustion gases from the vessel and means to separate entrained catalyst from the combustion gases, which vessel also comprises, in use, a fluidised bed zone of catalyst at its lower end, wherein in the fluidised bed zone a vertically extending partition, which partition is provided with one or more openings, is present dividing the fluidised bed zone in a dense phase fluidised bed zone and a fast-fluidised bed zone, the dense phase fluidised bed zone provided with the means to supply catalysts and the fast-fluidised bed zone provided with the means to supply an oxygenate gas at its lower end.
Patent MX-PA03010403-A (MX)
Title: Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors.
Inventor: CYNTHIA ANNE FINK
IPC: A61K38/00
Filed: 2002-05-14
Abstract: Compounds of formula (I) wherein R, R1, COOR2, R3-R7, alk, and X have meaning as defined, such being useful as dual inhibitors of angiotensin converting enzyme and neutral endopeptidase, as well as inhibitors of endothelin converting enzyme. In a preferred embodiment, R and R5 represent hydrogen; R1 represents benzyl; R3 represents hydrogen, acetyl or methoxyacetyl; R4 represents isopropyl or tert-butyl; R6 and R7 represent methyl; X represents -O-; alk represents methylene; and COOR2 represents carboxyl or ethoxycarbonyl.
Patent MX-PA03011951-A (MX)
Title: Diamine derivatives.
Inventor: KOUICHI UOTO
IPC: C07D417/14
Filed: 2002-06-20
Abstract: Compounds represented by the following general formula (1), salts thereof, solvates of the same or N-oxides of the same: Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 (1) wherein R1 and R2 represent each hydrogen, etc.; Q1 represents optionally substituted, saturated or unsaturated 5- or 6-membered hydrocarbyl, etc.; Q2 represents a single bond, etc.; Q3 represents the following group; (wherein Q5 represents C1-8 alkylene, etc.); and T0 and T1 represent each carbonyl, etc. These compounds are useful as preventives and/or remedies for brain infarction, cerebral embolism, myocardial infarction, angina, pulmonary infarction, pulmonary embolism, BuergerÔ¦¦s disease, bottom venous thrombosis, disseminated intravascular coagulation, thrombosis following artificial valve/joint replacement, thrombosis and reocclusion following circulation reconstruction, systemic inflammatory responsive syndrome (SIRS), multiple organ dysfunction (MODS), thrombosis in extracorporeal circulation or blood coagulation in collecting blood.
Patent MX-PA04000115-A (MX)
Title: Method and apparatus for controlling gain level of a supplemental channel in a cdma communication system.
Inventor: ETIENNE CHAPONNIERE
IPC: H04J13/00
Filed: 2002-06-17
Abstract: In a code division multiple access communication system (100), a method and accompanying apparatus provide for controlling gain of a forward supplemental channel (482) by determining gain level of a forward fundamental channel (481) associated with supplemental channel (482) for being targeted for a common mobile station, determining an adaptive margin (Ma) for fundamental channel (481) and determining a forward supplemental channel gain (Gsch) based on the gain of supplemental channel (482) and the Ma. The Gsch may be successively decreased for subsequent data frames targeted for the common mobile station on supplemental channel (482) by successively decreasing the Ma until receiving a supplemental channel frame erasure indicator from the common mobile station. The Gsch may be increased for a subsequent data frame targeted for the common mobile station on supplemental channel (482) by increasing the Ma after receiving the supplemental channel frame erasure indicator from the common mobile station.
Patent MX-PA04007041-A (MX)
Title: Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases.
Inventor: ANTHONY E BOLTON
IPC: A61K9/127
Filed: 2003-01-21
Abstract: This invention relates to synthetic and semi-synthetic compositions having biological activity, and to the uses thereof in the treatment and/or prophylaxis of various disorders in mammalian patients. More particularly it relates to preparation and use of synthetic and semi-synthetic bodies, which after introduction into the body of a patient, produce beneficial anti-inflammatory, organ protective and immune regulatory effects. The invention also relates to treatments and compositions for alleviating inflammatory and autoimmune diseases and their symptoms.
Patent MX-PA04008486-A (MX)
Title: Pharmaceutical and cosmetic compositions comprising plgf-1.
Inventor: MARINA TUCCI
IPC: A61K38/00
Filed: 2003-03-05
Abstract: The invention relates to the preparation of placental growth factor (PLGF)-comprising therapeutic and cosmetic compositions capable of increasing angiogenesis of the cutaneous, subcutaneous and internal organ connective tissue. Such compositions are suitable for the treatment of pathological or natural states benefiting from the formation or regeneration of new vessels of the cutaneous compartment, such as scleroderma , its various manifestations, skin ageing or loss of hair.
Patent MX-PA04008733-A (MX)
Title: Heterocyclic amide derivatives for the treatment of diabetes and other diseases.
Inventor: ZAPF JAMES W
IPC: C07D277/34
Filed: 2003-03-07
Abstract: The present invention relates to certain substituted heterocycles of Formula (200), wherein B, H, I, J and K together with the Ar5 form a ring containing at least one amide residue, and W, X, Y and Z together form a 2,4-thiazolidinedione, 2-thioxothiazolidine-4-one, 2,4-imidazolidinedione or 2-thioxo-imidazolidine-4-one residue; or a pharmaceutically acceptable salt thereof. The compounds are useful in the treatment of diseases such as type 2 diabetes, and related disorders of lipid and carbohydrate metabolism, including atherosclerosis. The compounds are also useful for treating diseases of uncontrolled proliferation, such as cancers in general, including breast cancer.
Patent MX-PA04010452-A (MX)
Title: Sms format mapping for different cellular systems.
Inventor: THADI M NAGARAJ
IPC: H04W88/18
Filed: 2003-04-22
Abstract: An apparatus and method of mapping a short message service (SMS) information from a first communications system (120) to a corresponding message in a second, different cellular system (116) is claimed. SMS information having a format required by the first communication system (120) is received. The SMS information is mapped into a format required by the second communication system (106). Additional information is appended, if necessary, or information is removed as being extraneous information, if necessary, as required by the second communication system (106).
Patent MX-PA04011687-A (MX)
Title: Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm.
Inventor: ANTON EGBERT ADANG
IPC: A61P19/08
Filed: 2003-05-20
Abstract: The subject invention provides a use of tibolone and a SERM for the manufacture of a medicine for the treatment of an estrogen-deficiency related complaint for the prevention of a recurrence of breast cancer in females suffering from, or at risk for breast cancer that exhibit the estrogen-deficiency related complaint.
Patent MX-PA04011883-A (MX)
Title: Absorbent article with multiple core.
Inventor: SERAFINO JEAN
IPC: A61F13/53
Filed: 2003-05-28
Abstract: An absorbent article is provided which includes a fluid permeable top sheet and a first absorbent core being separate and in fluid communication with a second absorbent core. The second absorbent core is separate and in fluid communication with a third absorbent core. The first, second and third absorbent cores are supported between the fluid permeable top sheet and a fluid impermeable back sheet. The second absorbent core defines at least two separate absorbent core sections in fluid communication. The separate absorbent core sections define a body facing surface that engages the fluid permeable top sheet. In an alternative embodiment, the absorbent article defines a longitudinal length and includes a fluid permeable top sheet and a first absorbent core disposed adjacent a side of a central second absorbent core and pivotable, along the longitudinal length, relative to the second absorbent core. A third absorbent core is disposed adjacent to an opposing side of the second absorbent core and pivotable, along the longitudinal length, relative to the second absorbent core. The second absorbent core has a mid-section and lateral sections disposed on opposing sides of the mid-section. The mid-section and lateral sections are separate, in fluid communication and define a body-facing surface that engages the fluid permeable top sheet. In another alternate embodiment, fluid flow channels are disposed between the absorbent cores and core sections for fluid management.
Patent MX-PA04012968-A (MX)
Title: Fission reactor for a claus plant.
Inventor: HOLGER THIELERT
IPC: C01B17/04
Filed: 2003-05-10
Abstract: The invention relates to a fission reactor (1) for a Claus plant, comprising a fireproof lined boiler (9), which contains a combustion chamber (2) with an influx opening for a mixture of fuel gas, air and acid gas containing H2S, a catalyst chamber (10) with a catalyst bed and a chamber on the outflow side (11) comprising a gas outlet for a hot process gas that contains elemental sulphur. According to the invention, the boiler is configured as a horizontal cylindrical boiler, in which the combustion chamber (2), the catalyst chamber and the chamber on the outflow side (11) are located next to one another. The catalyst chamber is delimited on both sides in the flow direction by gas-permeable chequer bricks (14) and has a fill opening (15) on the shell side for introducing the catalyst bed.
Patent MX-PA05001745-A (MX)
Title: Fitting for textile reinforced hose.
Inventor: CURL BRUCE L
IPC: F16L33/207
Filed: 2003-08-14
Abstract: A hose fitting suitable for use with a reinforced hose is provided that includes a longitudinally extending body having a hose end and a coupling end. The body includes an exterior surface and an interior opening. The exterior surface of body defines a gripping surface and a reinforcement trapping surface. Fitting also includes a socket surrounding the body. The socket defines an interior surface, which cooperates with the exterior surface of the body to define a generally cylindrical opening for receiving the hose. The interior surface of the socket is positioned radially outward of the gripping surface and the reinforcement trapping surface. The hose reinforcement is trapped between the interior surface and the reinforcement trapping surface to inhibit movement of the hose reinforcement.
Patent MX-PA05003079-A (MX)
Title: Method of increasing the output power from photovoltaic cells.
Inventor: BACHIR HIHI
IPC: F24S23/00
Filed: 2002-11-18
Abstract: The invention relates to a method of increasing the output power from photovoltaic cells with different known systems and of reducing to a minimum the temperature of photovoltaic cells, which negatively affects the voltage. The system used to perform the inventive method comprises prisms which are disposed on several adjacent surfaces, forming angles therebetween, and calculated such that all of the refracted light rays converge fully on the surface of the solar module. The material used for said prisms absorbs most of the ultraviolet rays.
Patent MX-PA05003505-A (MX)
Title: Laminated building panels having preselected colors.
Inventor: REGELSKI JOSEPH R JR
IPC: B32B27/28
Filed: 2005-04-01
Abstract: Plastic building panels for exterior use on buildings are made by forming a plastic sheet at an elevated temperature, overlaying an exterior surface portion of the formed sheet with a coloring sheet having a preselected color, and thermally bonding the coloring sheet to the formed sheet. The coloring sheet may comprise a vinyl resin plastisol and pigment particles. Both the formed sheet and the vinyl resin in the plastisol may comprise polyvinyl chloride (PVC). The coloring sheet can be configured with a matte surface substantially without the use of flattening agents, and an adhesion system can be used to augment the lamination between the coloring sheet and the plastic sheet. The coloring sheet can also be configured to have a predetermined pattern, such as may be provided with a plurality of coloring materials having multiple colors.
Patent MX-PA05006997-A (MX)
Title: Improved disposable absorbent article.
Inventor: SANCHEZ DAVID OCEJO
IPC: A61F13/00
Filed: 2005-06-27
Abstract: Herein is described a breathable disposable absorbent article that comprises: (a) a permeable upper layer, which receives discharges of liquid exudates; (b) an absorbent core that contains said liquid exudates; and (c) an impermeable rear layer that includes the following elements: a non-woven layer having an outer surface facing the user's undergarment and an inner layer facing the absorbent core; as well as an extrudable polymeric coat integrated into the inner surface of the rear layer useful for forming an impermeable coat therein.